You are here
- Home
- Total number of clinical trials
A phase-II, double-blind, placebo-controlled, randomised, parallel-group,multi-centre study to assess the efficacy and safety of two staggered dose levels of inhaled once daily AZD5423 or twice daily budesonide for 12 weeks in COPD patients on a background therapy of formoterol.
- Disease
- chronic obstructive pulmonary disease, pharmacokinetics
- Drug Name
- AZD5423
- Generic Name
- AZD5423
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- Jan 18, 1971
- Study Name
- D2340C00011
- Study Id
- D2340C00011
- ClinicalTrials.gov ID
- NCT01555099
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
